Skip to content
GraphTheory.in

Sisir Nandi

Global Institute of Pharmaceutical Education & Research (GIPER)IN
ORCID0000-0002-9960-6584
Claim this profile
h-index
19

via OpenAlex

Citations
1,231

via OpenAlex

Publications
161

About

Dr. Sisir Nandi completed Ph.D. from Indian Institute of Chemical Biology (CSIR), Kolkata as a CSIR -GATE fellow and had been awarded Ph. D. in Pharmacy degree (2011) by the Jadavpur University, India. He did his Post-Doctoral research based on the prediction of new promising cycloaddition reactions: quantum chemical calculations and reactions modeling at transition state levels using different basis sets and theory under the European Union Marie Curie fellowship in Laboratory of Chemometrics, National Institute of Chemistry, Ljubljana, Slovenia, Europe. His specialization is Pharmaceutical Chemistry and research is based on the area of Pharmacoinformatics related rational drug design which includes QSAR & drug design, biological activity prediction of lead compounds, ligand-receptor interactions, virtual screening, combinatorial library design and lead-hopping. He published more than 50 original research articles and reviews in reputed international journals having high impact factor. He presented his research work in many international conferences around the world. He is the reviewers of many research articles of medicinal chemistry, drug development technologies, combinatorial chemistry & High Throughput Screening. He is Editorial advisory board of Journal of Bioanalysis and Biomedicine, Journal of Developing Drugs, Advanced Techniques in Clinical Microbiology, Journal of Computational Methods in Molecular Design; Indo American Journal of Pharmacy, EC Microbiology, Guest Editor of Current Pharmaceutical Design, Current Signal Transduction Therapy and Associate Editor of Open Access Journal of Medicinal Chemistry; International Journal of Pharma Research and Health Sciences; Bioequivalence & Bioavailability International Journal (BEBA). He is having more than 12 years of research experience

Research areas

  • Chemistry
  • Medicine
  • Biology
  • Pharmacology
  • Biochemistry

Publications (161)

Sorted by most cited.

  1. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks

    Chemical Biology and Drug Design1970journal article

    View DOI
    74 cites

  2. 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: A rational approach to anticancer drug design

    Molecular Diversity1970journal article

    View DOI
    62 cites

  3. Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers

    2013

    View DOI
    51 cites

  4. Potential inhibitors of protein tyrosine phosphatase (PTP1B) enzyme: Promising target for type-II diabetes mellitus

    Current Topics in Medicinal Chemistry1970journal article

    View DOI
    41 cites

  5. Atranorin, an antimicrobial metabolite from lichen Parmotrema rampoddense exhibited in vitro anti-breast cancer activity through interaction with Akt activity

    Journal of Biomolecular Structure and Dynamics1970journal article

    View DOI
    36 cites

  6. “Pelargonidin mediated selective activation of p53 and parp proteins in preventing food additive induced genotoxicity: an in vivo coupled in silico molecular docking study”

    European Journal of Pharmaceutical Sciences1970journal article

    View DOI
    32 cites

  7. Exploring the potential inhibition of candidate drug molecules for clinical investigation based on their docking or crystallographic analyses against M. Tuberculosis enzyme targets

    Current Topics in Medicinal Chemistry1970journal article

    View DOI
    32 cites

  8. Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer Agents

    Current Medicinal Chemistry2022journal article

    View DOI
    29 cites

  9. Fibrin biomaterials for tissue regeneration and repair

    2017

    View DOI
    29 cites

  10. In-Silico Modeling in Drug Metabolism and Interaction: Current Strategies of Lead Discovery

    Current Pharmaceutical Design2019journal article

    View DOI
    28 cites

  11. An updated patent review on drugs for the treatment of tuberculosis (2018-present)

    Expert Opinion on Therapeutic Patents2022journal article

    View DOI
    25 cites

  12. A quality by design approach of metronidazole bigel and assessment of antimicrobial study utilizing box-behnken design

    Combinatorial Chemistry and High Throughput Screening1970journal article

    View DOI
    25 cites

  13. Combinatorial design and virtual screening of potent anti-tubercular fluoroquinolone and isothiazoloquinolone compounds utilizing QSAR and pharmacophore modelling$

    SAR and QSAR in Environmental Research1970journal article

    View DOI
    24 cites

  14. Stem Cell Therapy in Combination with Naturopathy: Current Progressive Management of Diabetes and Associated Complications

    Current Topics in Medicinal Chemistry2023journal article

    View DOI
    22 cites

  15. Transethosomes: Cutting edge approach for drug permeation enhancement in transdermal drug delivery system

    Chemical Biology and Drug Design1970journal article

    View DOI
    22 cites

  16. Recent advances in ligand and structure based screening of potent quorum sensing inhibitors against antibiotic resistance induced bacterial virulence

    Recent Patents on Biotechnology1970journal article

    View DOI
    20 cites

  17. Quantitative structure-activation barrier relationship modeling for Diels-Alder ligations utilizing quantum chemical structural descriptors

    Chemistry Central Journal1970journal article

    View DOI
    20 cites

  18. Natural Inhibitors against Potential Targets of Cyclooxygenase, Lipoxygenase and Leukotrienes

    Combinatorial Chemistry & High Throughput Screening2022journal article

    View DOI
    19 cites

  19. QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: Anticancer drug design by computed descriptors

    Journal of Enzyme Inhibition and Medicinal Chemistry1970journal article

    View DOI
    19 cites

  20. Chitosan based urapidil microparticle development in approach to improve mechanical strength by cold hyperosmotic dextrose solution technique

    Journal of Drug Delivery Science and Technology1970journal article

    View DOI
    18 cites

  21. Exploring Current Role of Nanotechnology Used in Food Processing Industry to Control Food Additives and their Biochemical Mechanisms

    Current Drug Targets2022journal article

    View DOI
    17 cites

  22. Chitosan Anchored Nanoparticles in Current Drug Development Utilizing Computer-Aided Pharmacokinetic Modeling: Case Studies for Target Specific Cancer Treatment and Future Prospective

    Current Pharmaceutical Design2020journal article

    View DOI
    17 cites

  23. Poly lactide-co-glycolide encapsulated nano-curcumin promoting antagonistic interactions between HSP 90 and XRCC1 proteins to prevent cypermethrin-induced toxicity: An in silico predicted in vitro and in vivo approach

    Colloids and Surfaces B Biointerfaces1970journal article

    View DOI
    16 cites

  24. Enhanced Drug Carriage Efficiency of Curcumin-Loaded PLGA Nanoparticles in Combating Diabetic Nephropathy via Mitigation of Renal Apoptosis

    Journal of Pharmacopuncture2024journal article

    View DOI
    15 cites

  25. Exploring the Role of Antioxidants to Combat Oxidative Stress in Malaria Parasites

    Current Topics in Medicinal Chemistry2022journal article

    View DOI
    15 cites

  26. Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic Anticancer Drug Design by Crystallography

    Anti-Cancer Agents in Medicinal Chemistry2022journal article

    View DOI
    15 cites

  27. Current Naturopathy to Combat Alzheimer’s Disease

    Current Neuropharmacology1970journal article

    View DOI
    15 cites

  28. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents

    Current Drug Targets1970journal article

    View DOI
    15 cites

  29. Phyto-chlorophyllin prevents food additive induced genotoxicity and mitochondrial dysfunction via cytochrome c mediated pathway in mice model

    Combinatorial Chemistry and High Throughput Screening1970journal article

    View DOI
    15 cites

  30. Novel PLGA-encapsulated-nanopiperine promotes synergistic interaction of p53/PARP-1/Hsp90 axis to combat ALX-induced-hyperglycemia

    Scientific Reports1970journal article

    View DOI
    14 cites

  31. Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking

    Letters in Drug Design & Discovery2022journal article

    View DOI
    13 cites

  32. QSAR and pharmacophore modeling of indole-based C-3 pyridone compounds as HCV NS5B polymerase inhibitors utilizing computed molecular descriptors

    Medicinal Chemistry Research1970journal article

    View DOI
    13 cites

  33. To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors

    Current Topics in Medicinal Chemistry2023journal article

    View DOI
    12 cites

  34. Morroniside interaction with poly (ADP-ribose) polymerase accentuates metabolic mitigation of alloxan-induced genotoxicity and hyperglycaemia: a molecular docking based in vitro and in vivo experimental therapeutic insight

    Journal of Biomolecular Structure and Dynamics1970journal article

    View DOI
    12 cites

  35. Recent breakthroughs in various antimicrobial resistance induced quorum sensing biosynthetic pathway mediated targets and design of their inhibitors

    Combinatorial Chemistry and High Throughput Screening1970journal article

    View DOI
    12 cites

  36. Importance of Kier-hall topological Indices in the QSAR of anticancer drug design

    Current Computer Aided Drug Design1970journal article

    View DOI
    12 cites

  37. In silico design of potent EGFR kinase inhibitors using combinatorial libraries

    Molecular Simulation1970journal article

    View DOI
    12 cites

  38. Activity Prediction of Some Nontested Anticancer Compounds Using GA-Based PLS Regression Models

    Chemical Biology and Drug Design1970journal article

    View DOI
    12 cites

  39. To quest new targets of Plasmodium parasite and their potential inhibitors to combat antimalarial drug resistance

    Journal of Parasitic Diseases2024journal article

    View DOI
    11 cites

  40. Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and Cancer

    Current Topics in Medicinal Chemistry2023journal article

    View DOI
    11 cites

  41. QSAR and molecular docking studies of lethal factor protease inhibitors against Bacillus anthracis

    SAR and QSAR in Environmental Research1970journal article

    View DOI
    11 cites

  42. In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors

    Springerplus1970journal article

    View DOI
    11 cites

  43. Repurposing of Chemotherapeutics to Combat COVID-19

    Current Topics in Medicinal Chemistry1970journal article

    View DOI
    10 cites

  44. Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis

    Current Medicinal Chemistry2024journal article

    View DOI
    9 cites

  45. Signal transduction through JAK-STAT and NF-κB regulated Pim-1 kinase: Novel target for anticancer leads

    Current Signal Transduction Therapy1970journal article

    View DOI
    9 cites

  46. Exploring the Targets of Novel Corona Virus and Docking-based Screening of Potential Natural Inhibitors to Combat COVID-19

    Current Topics in Medicinal Chemistry2022journal article

    View DOI
    8 cites

  47. QSAR and Structure Based Modeling of Marine Derived Anticancer Hymenialdisine Compounds

    2018

    View DOI
    8 cites

  48. Formulation of saquinavir mesylate loaded microparticle by counterion induced aggregation method: Approach by hyperosmotic technique

    Drug Invention Today1970journal article

    View DOI
    8 cites

  49. QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical Molecular Descriptors

    Letters in Drug Design & Discovery2024journal article

    View DOI
    7 cites

  50. EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design

    2016

    View DOI
    7 cites

  51. Important Targets and Inhibitors of Mycobacterium tuberculosis

    Integrated Science1970book chapter

    View DOI
    7 cites

  52. Graphene: the magic carbon derived biological weapon for human welfare

    International Journal of Experimental Research and Review1970journal article

    View DOI
    7 cites

  53. In silico factorial screening and optimization of chitosan based gel for urapidil loaded microparticle using reduced factorial design

    Combinatorial Chemistry and High Throughput Screening1970journal article

    View DOI
    7 cites

  54. QSAR modeling of 4-anilinofuro[2,3-b]quinolines: An approach to anticancer drug design

    Medicinal Chemistry Research1970journal article

    View DOI
    7 cites

  55. To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds

    Current Medicinal Chemistry2024journal article

    View DOI
    6 cites

  56. Selected Phytochemicals to Combat Lungs Injury: Natural Care

    Combinatorial Chemistry & High Throughput Screening2022journal article

    View DOI
    6 cites

  57. Exploring the SARS-Cov-2 Main Protease (Mpro) and RdRp Targets by Updating Current Structure-based Drug Design Utilizing Co-crystals to Combat COVID-19

    Current Drug Targets2022journal article

    View DOI
    6 cites

  58. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking

    Combinatorial Chemistry & High Throughput Screening2022journal article

    View DOI
    6 cites

  59. Poloxamer based Urapidil Loaded Chitosan Microparticle in Approach to Improve the Mechanical Strength by Tensile Strength and Entrapment Determination

    Current Drug Therapy2022journal article

    View DOI
    6 cites

  60. Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors

    Current Topics in Medicinal Chemistry2021journal article

    View DOI
    6 cites

  61. Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer

    Journal of Cancer Research Updates1970journal article

    View DOI
    6 cites

  62. Optimization and quality by design approach for piroxicam fast dissolving tablet formulations using Box-Behnken design

    Current Drug Therapy1970journal article

    View DOI
    6 cites

  63. QSAR and pharmacophore modeling of anti-tubercular 6-Fluoroquinolone compounds utilizing calculated structural descriptors

    Medicinal Chemistry Research1970journal article

    View DOI
    6 cites

  64. Aromatic Plants as Potential Resources to Combat Osteoarthritis

    Combinatorial Chemistry & High Throughput Screening2024journal article

    View DOI
    5 cites

  65. Current Development on Chitosan-based Antimicrobial Drug Formulations for the Wound Healing

    Current Drug Discovery Technologies2020journal article

    View DOI
    5 cites

  66. Current breakthroughs in structure-based design of synthetic and natural sourced inhibitors against zika viral targets

    Current Topics in Medicinal Chemistry1970journal article

    View DOI
    5 cites

  67. Design, synthesis and therapeutic exploration of nano-curcumin targeting the synergistic interactions with p53 and PARP-1 proteins in preventing food-additive induced genotoxicity and diabetic complications

    Colloids and Surfaces A Physicochemical and Engineering Aspects1970journal article

    View DOI
    5 cites

  68. [Final accepted version, unedited] Exploring the inhibitory mechanisms of indazole compounds against SAH/MTAN-mediated quorum sensing utilizing QSAR and docking

    Drug Target Insights2022journal article

    View DOI
    4 cites

  69. Antidepressant Drug Design on TCAs and Phenoxyphenylpropylamines Utilizing QSAR and Pharmacophore Modeling

    Combinatorial Chemistry & High Throughput Screening2022journal article

    View DOI
    4 cites

  70. The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking

    Combinatorial Chemistry & High Throughput Screening2020journal article

    View DOI
    4 cites

  71. QSAR and Structure-Based Docking Studies of Aryl Pyrido[2,3-d]pyrimidin-7(8H)-ones

    2017

    View DOI
    4 cites

  72. Exploring the pathoprofiles of SARS-COV-2 infected human gut-lungs microbiome crosstalks

    Probiotics Prebiotics Synbiotics and Postbiotics Human Microbiome and Human Health1970book chapter

    View DOI
    4 cites

  73. Exploring the COVID-19 potential targets: Big challenges to quest specific treatment

    Current Topics in Medicinal Chemistry1970journal article

    View DOI
    4 cites

  74. Abnormal signal transduction via over-expression of pim-1 regulated senescence, cell cycle, apoptosis and metastatic invasion: Novel anticancer targets and their potent inhibitors from marine sources

    Current Signal Transduction Therapy1970journal article

    View DOI
    4 cites

  75. Design of fast dissolving amlodipine besylate tablet formulations

    Asian Journal of Pharmaceutics1970journal article

    View DOI
    4 cites

  76. Exploring a new phyto-derived nanoparticle for targeting bacterial protein EF-Tu: an integrated approach to develop antimicrobial drug

    Smart Science1970journal article

    View DOI
    4 cites

  77. Exploring the Targets of Dengue Virus and Designs of Potential Inhibitors

    Combinatorial Chemistry & High Throughput Screening2024journal article

    View DOI
    3 cites

  78. QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical Molecular Descriptors

    Research Square2022preprint

    View DOI
    3 cites

  79. Repurposing of Potent Mtase Inhibitors Against ZIKV Utilizing Structure-Based Molecular Docking

    2020

    View DOI
    3 cites

  80. Optimization and Quest of HPMC loaded Stavudine Controlled Release Dosage Development by Central Composite Design utilizing Reduced Factorial Screening Technique

    Brazilian Journal of Pharmaceutical Sciences1970journal article

    View DOI
    3 cites

  81. Identification of therapeutically active molecules against anthrax through structure and ligand based drug design

    Current Topics in Medicinal Chemistry1970journal article

    View DOI
    3 cites

  82. QSAR of chalcones utilizing theoretical molecular descriptors

    Current Computer Aided Drug Design1970journal article

    View DOI
    3 cites

  83. QSAR analysis of BABQ compounds via calculated molecular descriptors

    Medicinal Chemistry Research1970journal article

    View DOI
    3 cites

  84. Structure-based drug design of pre-clinical candidate nanopiperine: a direct target for CYP1A1 protein to mitigate hyperglycaemia and associated microbes

    SAR and QSAR in Environmental Research1970journal article

    View DOI
    3 cites

  85. Curcumin Mitigates Streptozotocin-Induced Genotoxicity In Vivo by Activating P53 Protein and Inhibiting Oxidative Stress and Chromosomal Aberration

    Combinatorial Chemistry & High Throughput Screening2025journal article

    View DOI
    2 cites

  86. QSAR and Anticancer Drug Design on Benzothienopyrimidinones as Promising Pim Kinase Inhibitors Utilizing Structural Descriptors

    2019

    View DOI
    2 cites

  87. Pharmacophore Modeling of Furanosyl Borate Diester: An Attempt to Combat Antibiotic Resistance Induced Helicobacter pylori Quorum Sensing Mediated Peptic and Duodenal Ulcer

    2018

    View DOI
    2 cites

  88. Quantitative Regression Analysis of Total Hardness Related Physicochemical Parameters of Groundwater

    2018

    View DOI
    2 cites

  89. Can animal and in vitro studies give new, relevant answers to questions concerning mammorgraphic screening for human breast cancer?

    1978

    2 cites

  90. Current drug design strategies for fighting against swine influenza

    Current Drug Therapy1970journal article

    View DOI
    2 cites

  91. In silico evaluation of 6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7(8H)-one compounds: An insight into design of less toxic anticancer drugs

    Medicinal Chemistry Research1970journal article

    View DOI
    2 cites

  92. Correction: Nano-pelargonidin modulates p53/PARP/HSP 90/XRCC1 signaling axis to combat cypermethrin-induced genotoxicity and metabolic dysfunction in fish: a molecular docking predicted in vivo approach

    Environmental Science: Nano1970journal article

    View DOI
    2 cites

  93. To Explore Potential Inhibitors against Various Enzymatic Targets of Human African Trypanosomiasis

    Combinatorial Chemistry & High Throughput Screening2025journal article

    View DOI
    1 cites

  94. Exploring the Biochemical Mechanisms of Fluoroquinolone Compounds against Tuberculosis by Utilizing Molecular Docking and Quantitative Structure-amino Acid Relationship

    Letters in Drug Design & Discovery2024journal article

    View DOI
    1 cites

  95. Exploration of Potential Cyclin-dependent Kinases and their Inhibitors to Combat Abnormal Signalling and Cancer

    Current Signal Transduction Therapy2024journal article

    View DOI
    1 cites

  96. QSAR of 1,3,5-triazine compounds towards inhibition of toxoplasmosis utilizing computed molecular descriptors

    2020

    1 cites

  97. QSAR Modeling of CCK2 Receptor Antagonists Utilizing Computed Structural Indices

    2019

    View DOI
    1 cites

  98. Nipah Viral Virulence may be Due to Resistant Strains Amplified by Cross- Species Transmission between Animals and Humans

    2018

    View DOI
    1 cites

  99. Adjuvant Phytotherapy against Antitubercular Drug Induced Hepatotoxicity

    2016

    View DOI
    1 cites

  100. QSAR and pharmacophore modeling of aminopyridazine derivatives of γ-aminobutyric acid as selective GABA-A receptor antagonists against induced coma

    2015

    View DOI
    1 cites

  101. Microbes in the Baking Industry: Harnessing the Power of Microbes in Baking Products

    Microbial Products for Health and Nutrition1970book chapter

    View DOI
    1 cites

  102. Natural Drugs to Combat Dengue Fever

    1970book chapter

    View DOI
    1 cites

  103. Erdafitinib can combat FGFR-mediated abnormal signaling in cancer

    Cancer Research Statistics and Treatment1970journal article

    View DOI
    1 cites

  104. Potential Biomedical Applications of Marine Sponge-Derived Chitosan: Current Breakthroughs in Drug Delivery for Wound Care

    Wound Healing Research Current Trends and Future Directions1970book chapter

    View DOI
    1 cites

  105. To explore the potential targets and current structure-based design strategies utilizing co-crystallized ligand to combat hcv

    Current Drug Targets1970journal article

    View DOI
    1 cites

  106. Recent trends in design and developments of new drugs for the treatment of cancer, rheumatoid arthritis, and Parkinson’s disease-associated to abnormal signal transduction

    Current Signal Transduction Therapy1970journal article

    View DOI
    1 cites

  107. Enhanced rivastigmine delivery through nanoemulsion and pyridoxine supplementation: An in-vivo study on Alzheimer's disease intervention

    Nanomedicine Nanotechnology Biology and Medicine1970journal article

    View DOI
    1 cites

  108. To explore molecular targets and combination antimalarial chemotherapeutics as tissue and erythrocytic schizonticides

    Journal of Parasitic Diseases2026journal article

    View DOI
    0 cites

  109. An update on PDGFR inhibitors: a patent review (2020 - present)

    2026

    View DOI
    0 cites

  110. A biogenic computational framework for designing synergistic antimicrobial silver nanodrugs

    2026

    View DOI
    0 cites

  111. Central Composite Design-Based Optimization and Formulation of Capecitabine Nanosuspension for Improved Gastric Cancer Therapy

    Drug Delivery Letters2026journal article

    View DOI
    0 cites

  112. Cyclic Peptides in Wound Hydrogels: Current Advances and Future Directions

    Current Drug Discovery Technologies2026journal article

    View DOI
    0 cites

  113. Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches

    2026

    View DOI
    0 cites

  114. Formulation, Optimization and Design of Capecitabine Nanosuspension to Enhance the Anti-Gastric Cancer Efficacy using Box-Behnken Quality-based Design Study

    Current Drug Discovery Technologies2026journal article

    View DOI
    0 cites

  115. Quantitative Structure-Activity-Amino Acid Relationship of Benzodiazepines and Thienodiazepine via Molecular Docking Simulation

    Current Drug Discovery Technologies2025journal article

    View DOI
    0 cites

  116. To Explore Potential Targets and their Natural Inhibitors to Combat Diabetes

    2025

    View DOI
    0 cites

  117. To Explore Potential Natural Inhibitors of Cysteine Proteases to Combat Human African Trypanosomiasis and Chagas Disease

    Current Medicinal Chemistry2024journal article

    View DOI
    0 cites

  118. Enhanced Rivastigmine Delivery Through Nanoemulsion and Pyridoxine Supplementation: An In-Vivo Study on Alzheimer's Disease Intervention

    2024

    View DOI
    0 cites

  119. To Quest Common Dangerous Bacterial Attack in Drinking Water

    2023

    View DOI
    0 cites

  120. Review of: "Natural Polyphenols of Pomegranate and Black Tea Juices can Combat COVID-19 through their SARS-CoV-2 3C-like Protease-inhibitory Activity"

    2023

    View DOI
    0 cites

  121. Review of: "[Commentary] Polymerized Type I Collagen (Fibroquel) as a treatment for COVID-19, Mexican experience"

    2023

    View DOI
    0 cites

  122. Optimization and Quest of HPMC loaded Stavudine Controlled Release Dosage Development by Central Composite Design utilizing Reduced Factorial Screening Technique

    2023

    View DOI
    0 cites

  123. Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma

    2022

    View DOI
    0 cites

  124. Referee report. For: A Review of Wound Healing Mechanisms of Natural Products in Keratinocyte Cells [version 1; peer review: 1 approved with reservations, 2 not approved]

    2022

    View DOI
    0 cites

  125. Exploring the Abnormal Signal Transduction Mediated Internet Addiction and Gaming Disorders

    Current Signal Transduction Therapy2021journal article

    View DOI
    0 cites

  126. Prediction of agonist, partial agonist and full antagonist of H. pylori TlpB utilizing molecular docking

    2021

    0 cites

  127. School-based Prediction and Prevention of Adolescent Internet Addiction towards Touch Screen Mobile by Motivational Therapy

    2020

    0 cites

  128. Referee report. For: Anti-infective potential of hydroalcoholic extract of Punica granatum peel against gram-negative bacterial pathogens [version 1; referees: 1 approved, 1 approved with reservations]

    2019

    View DOI
    0 cites

  129. To Quest Common Dangerous Bacterial Attack in Drinking Water

    2018

    View DOI
    0 cites

  130. Why is Heart Rarely Affected by Cancer?

    2017

    View DOI
    0 cites

  131. QSAR and Structure Based Molecular Docking of Angelicin Compounds: an Attempt to Drug Design against Swine Influenza

    2016

    View DOI
    0 cites

  132. Side Effects of Baby Milk Powders: Awareness to the Lactating Mothers

    2016

    View DOI
    0 cites

  133. Anticancer Drug Design Utilizing Pharmacoinformatics

    2016

    View DOI
    0 cites

  134. Prion : the novel infectious pathogen

    2000

    0 cites

  135. Modelling of the Cyclic Guanidines as 5 ‐ HT5A Receptor Ligands Using Chemometric Tools

    1970book chapter

    View DOI
    0 cites

  136. Nano-pelargonidin modulates p53/PARP/HSP 90/XRCC1 signaling axis to combat cypermethrin-induced genotoxicity and metabolic dysfunction in fish: a molecular docking predicted in vivo approach

    Environmental Science Nano1970journal article

    View DOI
    0 cites

  137. Oncolytic Viral Therapy: A Promising Approach in Cancer Treatment

    1970book chapter

    View DOI
    0 cites

  138. Pharmacophore Modeling of Tricyclic Antipsychotics

    1970book chapter

    View DOI
    0 cites

  139. QSAR of Repurposed Anti-COVID-19 Chemotherapeutics Utilizing Theoretical Structural Descriptors

    1970book chapter

    View DOI
    0 cites

  140. Tuberculosis: Integrated Studies for a Complex Disease 2050

    Integrated Science1970book chapter

    View DOI
    0 cites

  141. Age Related Osteoarthritis: Regenerative Therapy, Synthetic Drugs, and Naturopathy to Combat Abnormal Signal Transduction

    Current Signal Transduction Therapy1970journal article

    View DOI
    0 cites

  142. Natural Sourced Traditional Indian and Chinese Medicines to Combat COVID-19

    Pharmaceuticals for Targeting Coronaviruses1970book chapter

    View DOI
    0 cites

  143. Drug design utilizing molecular docking based binding analyses of human 5ht-transporter inhibitors to combat internet addiction and gaming disorders

    Recent Advances in Computer Aided Drug Designing1970book chapter

    0 cites

  144. High Throughput Screening of Focused Virtual Library and Synthetic Protocols of Marine Sponge Derived Hymenialdisine Analogs as Potential Abnormal Signal Transduction Inhibitors

    Current Signal Transduction Therapy1970journal article

    View DOI
    0 cites

  145. Physicochemical assessment of groundwater quality at Kashipur (Uttarakhand) industrial areas

    Indian Journal of Geo Marine Sciences1970journal article

    0 cites

  146. Prediction of agonist, partial agonist and full antagonist of H. pylori TlpB utilizing molecular docking

    Indian Journal of Chemistry Section B Organic and Medicinal Chemistry1970journal article

    0 cites

  147. QSAR of 1,3,5-Triazine compounds towards inhibition of toxoplasmosis utilizing computed molecular descriptors

    Indian Journal of Chemistry Section B Organic and Medicinal Chemistry1970journal article

    0 cites

  148. Editorial: Current pharmaceutical innovations and implementation of in-silico models with designs of promising lead molecules and formulations

    Current Pharmaceutical Design1970journal article

    View DOI
    0 cites

  149. Recent drug targets associated to abnormal signal transduction mediated cancer, rheumatoid arthritis, Alzheimer's and Parkinson's disease

    Current Signal Transduction Therapy1970journal article

    View DOI
    0 cites

  150. The antiviral and antimalarial drug repurposing in quest of chemotherapeutics to combat covid-19 utilizing structure-based molecular docking

    Combinatorial Chemistry and High Throughput Screening1970journal article

    View DOI
    0 cites

  151. Docking Based Screening of Potent Natural Components to Combat COVID-19-Associated Brain Fog

    1970book chapter

    View DOI
    0 cites

  152. Pathogenesis, Mode of Treatment and to Explore Current Targets of Trypanosomiasis

    1970book chapter

    View DOI
    0 cites

  153. Quantitative Structure Pharmacophore–Activity Relationship of Tricyclic Antidepressant (TCAs) Utilizing Distance–Based Features

    1970book chapter

    View DOI
    0 cites

  154. To Explore Biochemical Mechanisms of Chemo Preventives Against Colorectal Cancer Utilizing Docking Simulation

    1970book chapter

    View DOI
    0 cites

  155. Nano-curcumin promotes molecular interplay with PARP-1 and p53 proteins for therapeutic management of food-additive induced hyperglycemia in mice and L6 cells model: a molecular docking coupled experimental insight

    Smart Science1970journal article

    View DOI
    0 cites

  156. Green Synthesis of Chlorophyllin-Based Ag Nanoparticles to Target Escherichia coli and Staphylococcus aureus

    Recent Advances in Drug Delivery and Formulation1970journal article

    View DOI
    0 cites

  157. To Combat Abnormal Cell Signaling Mediated Gastrointestinal Cancer by Therapeutic Modulation of Gut Microbiota Utilizing Prebiotics, Postbiotics, and Synbiotics

    Current Cancer Drug Targets1970journal article

    View DOI
    0 cites

  158. Unveiling the nano-particle enabled synergistic mitigation of the Bcl2/Cyt c/CYP1A1 signaling axis as a protective therapeutic route in mitochondrial dysfunction associated diabetes

    Materials Advances1970journal article

    View DOI
    0 cites

  159. Docking-Based Experimental Approach Examining the Effectiveness of Nano-formulations as Diabetes Therapeutics

    1970book chapter

    View DOI
    0 cites

  160. Effects of Commonly Used Pesticides on Gut Microbiota

    1970book chapter

    View DOI
    0 cites

  161. Enhanced Rivastigmine Delivery Through Nanoemulsion and Pyridoxine Supplementation: An In-Vivo Study on Alzheimer's Disease Intervention

    Ssrn1970other

    0 cites